Abstract
Carrier determination is important for genetic counselling in DMD/BMD families. The detection of altered PCR amplified dystrophin mRNA fragments owing to deletions, insertions, or point mutations has increased the possibilities of carrier determination. However, problems may occur because of alternative splicing events. Here we present a family with a DMD patient characterised by a deletion of exons 45 to 54. At the mRNA level we detected a corresponding altered fragment which served for carrier determination. The mother and the sister of the patient showed the same altered dystrophin mRNA fragment as the patient and are therefore carriers. In the mother two additional altered dystrophin mRNA fragments were detectable, obviously resulting from alternative splicing in the normal allele. The grandmother and two other related females of the patient possess only the normal mRNA fragment. In a further female we detected an altered fragment owing to an mRNA deletion of exon 44. This fragment is created either by alternative splicing or a new mutation. Therefore, the carrier status of this female is still ambiguous indicating problems in carrier determination by the method of dystrophin mRNA analysis.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bakker E., Bonten E. J., De Lange L. F., Veenema H., Majoor-Krakauer D., Hofker M. H., Van Ommen G. J., Pearson P. L. DNA probe analysis for carrier detection and prenatal diagnosis of Duchenne muscular dystrophy: a standard diagnostic procedure. J Med Genet. 1986 Dec;23(6):573–580. doi: 10.1136/jmg.23.6.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chelly J., Concordet J. P., Kaplan J. C., Kahn A. Illegitimate transcription: transcription of any gene in any cell type. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2617–2621. doi: 10.1073/pnas.86.8.2617. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chelly J., Gilgenkrantz H., Hugnot J. P., Hamard G., Lambert M., Récan D., Akli S., Cometto M., Kahn A., Kaplan J. C. Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients. J Clin Invest. 1991 Oct;88(4):1161–1166. doi: 10.1172/JCI115417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chelly J., Gilgenkrantz H., Lambert M., Hamard G., Chafey P., Récan D., Katz P., de la Chapelle A., Koenig M., Ginjaar I. B. Effect of dystrophin gene deletions on mRNA levels and processing in Duchenne and Becker muscular dystrophies. Cell. 1990 Dec 21;63(6):1239–1248. doi: 10.1016/0092-8674(90)90419-f. [DOI] [PubMed] [Google Scholar]
- Chelly J., Kaplan J. C., Maire P., Gautron S., Kahn A. Transcription of the dystrophin gene in human muscle and non-muscle tissue. Nature. 1988 Jun 30;333(6176):858–860. doi: 10.1038/333858a0. [DOI] [PubMed] [Google Scholar]
- Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
- Ehrenpreis J., Hillers M., Junkes B., Pfordt M., Schwinger E., Vosberg H. P. Analysis of a dystrophin gene deletion by amplification of mRNA isolated from DMD myotubes cultured in vitro. Genomics. 1991 Jul;10(3):551–557. doi: 10.1016/0888-7543(91)90435-h. [DOI] [PubMed] [Google Scholar]
- Laing N. G., Siddique T., Bartlett R., Yamaoka L. H., Hung W. Y., Pericak-Vance M. A., Roses A. D. Duchenne muscular dystrophy: detection of deletion carriers by spectrophotometric densitometry. Clin Genet. 1989 Jun;35(6):393–398. doi: 10.1111/j.1399-0004.1989.tb02963.x. [DOI] [PubMed] [Google Scholar]
- Love D. R., England S. B., Speer A., Marsden R. F., Bloomfield J. F., Roche A. L., Cross G. S., Mountford R. C., Smith T. J., Davies K. E. Sequences of junction fragments in the deletion-prone region of the dystrophin gene. Genomics. 1991 May;10(1):57–67. doi: 10.1016/0888-7543(91)90484-v. [DOI] [PubMed] [Google Scholar]
- Roberts R. G., Barby T. F., Manners E., Bobrow M., Bentley D. R. Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet. 1991 Aug;49(2):298–310. [PMC free article] [PubMed] [Google Scholar]
- Roberts R. G., Bentley D. R., Barby T. F., Manners E., Bobrow M. Direct diagnosis of carriers of Duchenne and Becker muscular dystrophy by amplification of lymphocyte RNA. Lancet. 1990 Dec 22;336(8730):1523–1526. doi: 10.1016/0140-6736(90)93305-9. [DOI] [PubMed] [Google Scholar]
- Schloesser M., Slomski R., Wagner M., Reiss J., Berg L. P., Kakkar V. V., Cooper D. N. Characterization of pathological dystrophin transcripts from the lymphocytes of a muscular dystrophy carrier. Mol Biol Med. 1990 Dec;7(6):519–523. [PubMed] [Google Scholar]
- Speer A., Kräft U., Hanke R., Grade K., Coutelle C., Wulff K., Wehnert M., Herrmann F. H., Kadasi L., Kunert E. Deletion analysis of DMD/BMD families from the German Democratic Republic and selected regions of Czechoslovakia and Hungary. J Med Genet. 1990 Nov;27(11):679–682. doi: 10.1136/jmg.27.11.679. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Szpirer C., Rivière M., Szpirer J., Genet M., Drèze P., Islam M. Q., Levan G. Assignment of 12 loci to rat chromosome 5: evidence that this chromosome is homologous to mouse chromosome 4 and to human chromosomes 9 and 1 (1p arm). Genomics. 1990 Apr;6(4):679–684. doi: 10.1016/0888-7543(90)90504-n. [DOI] [PubMed] [Google Scholar]
- den Dunnen J. T., Bakker E., Breteler E. G., Pearson P. L., van Ommen G. J. Direct detection of more than 50% of the Duchenne muscular dystrophy mutations by field inversion gels. Nature. 1987 Oct 15;329(6140):640–642. doi: 10.1038/329640a0. [DOI] [PubMed] [Google Scholar]